Latest Content

After 11 Years With Cancer, What Is Enough Time?

December 5th 2025, 10:00pm

By Kim Johnson

Article

I believe time to be a gift, and as such, my sister was gifted more than a decade despite a terminal illness, and I do have gratitude for that.

How Therapeutic Vaccines May Transform Lung Cancer Care

December 5th 2025, 9:00pm

By Dr. Thomas Marron

Video

Dr. Thomas Marron explains how therapeutic vaccines differ from preventative vaccines in lung cancer care.

How Bispecific Antibodies Work to Treat Patients With Multiple Myeloma

December 5th 2025, 8:00pm

By Dr. Amany Keruakous

Video

Dr. Amany Keruakous discussed how bispecific antibodies for multiple myeloma work by simultaneously targeting cancer cells and T cells.

It’s Okay Not To Be Okay Through a Cancer Diagnosis

December 5th 2025, 6:00pm

By Linda Cohen

Article

Facing my cancer diagnosis, I learned it’s okay not to be okay and found comfort in laughter, honesty, and the support of loved ones.

Essential Insights on GIST and Gleevec for Patients

December 5th 2025, 5:00pm

By Dr. Ajay Gupta

Video

Dr. Ajay Gupta of the Roswell Park Comprehensive Cancer Center discussed basics of gastrointestinal stromal tumors.

TARA-002 Shows Potential in BCG-Naive NMIBC Treatment

December 5th 2025, 4:00pm

By Ryan Scott

Article

TARA-002 may offer meaningful benefits for patients with non-muscle invasive bladder cancer, including those who have limited treatment options.

What Patients With AML Need to Know About Azacitidine and Venclexta

December 5th 2025, 2:00pm

By Dr. Daniel Peters

Video

Dr. Daniel Peters discussed targeted therapies and regimens that patients with acute myeloid leukemia, or AML, should be aware of.

FDA Approves Breyanzi in Relapsed/Refractory Marginal Zone Lymphoma

December 4th 2025, 10:54pm

By Alex Biese

Article

The FDA approved Breyanzi for adults with relapsed or refractory marginal zone lymphoma who received at least two prior lines of systemic therapy.

11 Years Living With Stage 4 Cancer Inspires Gratitude and Reflection

December 4th 2025, 10:00pm

By Martha Carlson

Article

I’ve lived with stage 4 breast cancer for 11 years, and each day brings gratitude for my family, my oncologist, and the care that keeps me going.

An Educational Overview of Newly Diagnosed Stage 1 Myelofibrosis

December 4th 2025, 9:00pm

By Ryan Scott

Article

Stage 1 myelofibrosis is a manageable early-stage blood cancer that requires ongoing monitoring and personalized care to support long-term health.

Chemo Side Effects for Breast Cancer Led to Weeks in the Hospital

December 4th 2025, 8:00pm

By Alex Biese

Article

As part of her journey with stage 3 inflammatory breast cancer, Lindsey Gunter experienced chemotherapy side effects so severe that she was unable to walk.

Advice From a Cancer Survivor: Keep Your Appointments!

December 4th 2025, 6:00pm

By Mary Sansone

Article

I experienced acute myeloid leukemia twice. Had it not been for follow up appointments I would not be here.

Understanding Squamous Cell Lung Cancer and Common Treatment Paths

December 4th 2025, 5:00pm

By Spencer Feldman

Article

This guide explains how squamous cell lung cancer is diagnosed and treated at each stage to help patients talk openly with their oncology team.

LYMPHIR Launches in U.S., Bringing New Option for Stage 1 to 3 CTCL

December 4th 2025, 4:00pm

By Ryan Scott

Article

The U.S. commercial launch of LYMPHIR offers a new treatment option for patients with relapsed/refractory stage 1 to 3 cutaneous T-cell lymphoma.

What Patients Should Know About EGFR Mutated Lung Cancer Treatment

December 4th 2025, 2:00pm

By Dr. Girindra Raval

Video

Dr. Girindra Raval sat down for an interview with CURE to discuss what patients with EGFR-mutated lung cancer should know about their treatment options.